These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 3805802
1. Short term WHO advised multiple drug treatment of paucibacillary patients. Naafs B, Lyons NF, Matemera BO, Ellis BP. Indian J Lepr; 1986; 58(2):348-53. PubMed ID: 3805802 [No Abstract] [Full Text] [Related]
3. Multidrug therapy regimen for leprosy. Firooz A. J Am Acad Dermatol; 2006 Dec 01; 55(6):1115; author reply 1115. PubMed ID: 17110233 [No Abstract] [Full Text] [Related]
4. Multidrug therapy in leprosy. Manglani PR, Arif MA. J Indian Med Assoc; 2006 Dec 01; 104(12):686-8. PubMed ID: 17474286 [Abstract] [Full Text] [Related]
5. Experience with multidrug therapy in paucibacillary leprosy. Bhate RD, Gupta CM, Chattopadhyay SP, Singh IP. Indian J Lepr; 1986 Dec 01; 58(2):244-50. PubMed ID: 3805797 [Abstract] [Full Text] [Related]
6. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY, Ran SP, Weng XM, Li TG, Deng XH, Li FT. Indian J Lepr; 2001 Dec 01; 73(1):1-10. PubMed ID: 11326592 [Abstract] [Full Text] [Related]
7. [Therapy of leprosy today]. Bahmer FA, Menzel S. Hautarzt; 1987 Jan 01; 38(1):1-3. PubMed ID: 3557977 [Abstract] [Full Text] [Related]
8. Fixed duration MDT in paucibacillary leprosy (classical and modified). Nadkarni NJ, Grugni A, Kini MS. Int J Lepr Other Mycobact Dis; 1993 Mar 01; 61(1):25-8. PubMed ID: 8326177 [Abstract] [Full Text] [Related]
9. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR, Shrestha K, Pandey B, Walker SL. Lepr Rev; 2008 Dec 01; 79(4):425-8. PubMed ID: 19274989 [Abstract] [Full Text] [Related]
10. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency. Mysore V, al-Suwaid AR. Int J Lepr Other Mycobact Dis; 1999 Jun 01; 67(2):159-61. PubMed ID: 10472369 [No Abstract] [Full Text] [Related]
11. [How should leprosy be treated?]. Mahé A. Ann Dermatol Venereol; 1998 Dec 01; 125(12):881-3. PubMed ID: 9922859 [No Abstract] [Full Text] [Related]
12. [New WHO recommendations for the treatment of leprosy]. Acta Leprol; 1997 Dec 01; 10(4):189. PubMed ID: 9527754 [No Abstract] [Full Text] [Related]
13. A overview of ocular leprosy after 2 decades of multidrug therapy. Lewallen S, Courtright P. Int Ophthalmol Clin; 2007 Dec 01; 47(3):87-101. PubMed ID: 17667278 [No Abstract] [Full Text] [Related]
14. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five? Kumarasinghe SP, Kumarasinghe MP. Int J Lepr Other Mycobact Dis; 2004 Jun 01; 72(2):173-4. PubMed ID: 15301583 [No Abstract] [Full Text] [Related]
15. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF. Lepr Rev; 1986 Dec 01; 57 Suppl 1():61-7. PubMed ID: 3295437 [No Abstract] [Full Text] [Related]
16. Polytherapy in multibacillary leprosy patients in Nepal. Samuel NM, Samual S, Fairbairn T, Adiga RB. Singapore Med J; 1985 Apr 01; 26(2):203-6. PubMed ID: 4035403 [No Abstract] [Full Text] [Related]
17. Multi-drug therapy in leprosy: an effective method of control. Indian J Lepr; 1984 Apr 01; 56(1):102-12. PubMed ID: 6548238 [Abstract] [Full Text] [Related]
18. Recent trends in chemotherapy of leprosy. Parikh DA, Maniar JK, Parikh AC, Ganapati R. J Assoc Physicians India; 1985 Sep 01; 33(9):593-5. PubMed ID: 3912375 [No Abstract] [Full Text] [Related]
19. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS. Lepr Rev; 2003 Jun 01; 74(2):141-7. PubMed ID: 12862255 [Abstract] [Full Text] [Related]
20. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R, Revankar CR, Pai VV, Kingsley S. Int J Lepr Other Mycobact Dis; 1999 Sep 01; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]